News & Articles

Anti-cancer drug delivery to target tumor sites now becomes more effective with novel multi-stimuli-responsive drug delivery systems

The MDC Lighthouse Lab in Cheshire, which plays a key role in the UK Government’s COVID-19 testing rollout, has announced it has processed its 10 millionth test

Dr. Tania Nolan outlines how her team is designing assays to identify new variants and why these are critical to managing the global response

Each line of ValuPanel Reagents consists of separately delivered probes and primers, which allow assay flexibility and sizes that can help facilitate scale-up

AI could hold the key to more targeted treatment, according to new research

Watch world-leading scientists online, May 11-12, to discover the latest tools and techniques advancing COVID-19 research, immunotherapy development, drug screening, cancer diagnostics and more

The BinaxNOW Self-Test will be sold in 2-count packs for an MSRP of $23.99, making it an affordable over-the-counter COVID-19 rapid test available in the U.S.

In a ten-year project, a team from the Karl Landsteiner University of Health Sciences has identified a previously unknown role of calcium channels in the formation of synaptic connections

This feature will allow a greater number of patient samples to be processed faster

This collaboration enables improved integration of software and robotics platforms to maximize COVID-19 testing throughput and efficiency

Catch up on this on-demand webinar and register for part 2 to learn everything you need to know to get ready for IVDR

Potent antibodies shown to retain binding to major COVID-19-causing “South African” variant

The partnership will accelerate clinical validation and commercialization of certain NGS, mass spectrometry and immunology diagnostic tools

By consolidating up to four analytical units on a single platform, testing efficiency in high-volume labs is increased

Therapy used for the treatment of certain patients with locally advanced or metastatic esophageal or gastroesophageal junction carcinoma

Twist Biopharma will leverage its biologics and proprietary discovery capabilities to find novel GPCR target-specific antibodies for Kyowa Kirin

Innovative qPCR platform simplifies molecular diagnostic workflows for infectious disease, oncology and COVID-19 testing

The assay has the ability to sequence and surveil evolution of virus mutations over time and geography

This study offers new insights into high grade serous ovarian cancer that have the potential to make an impact in how patients are treated in the future

This partnership aims to offer an accelerated route to market rapid test technologies

Lenco Diagnostic Laboratories among first to offer Beckman Coulter’s semi-quantitative antibody test